[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100389474":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":29,"locations":35,"responsibleParty":51,"collaborators":18,"id":53,"slug":18,"hasResults":54,"nctId":55,"briefTitle":56,"officialTitle":57,"acronym":18,"eligibilityCriteria":58,"healthyVolunteers":54,"sex":59,"minAge":18,"maxAge":18,"enrollmentInfo":60,"targetDuration":18,"studyType":63,"phases":64,"briefSummary":67,"conditions":68,"keywords":18,"overallStatus":37,"whyStopped":18,"lastUpdateSubmitDate":70,"lastUpdatePostDateStruct":71,"startDateStruct":74,"completionDateStruct":76,"leadSponsor":78,"locationsCount":79},{"fullName":5,"class":6},"Tanta University","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Ivermectin","EXPERIMENTAL","Ivermectin alone in larger doses",[13],"Drug: Ivermectin",{"label":15,"type":16,"description":17,"interventionNames":18},"Standard treatment","NO_INTERVENTION","Standard of care treatment",null,[20],{"type":21,"name":9,"description":22,"armGroupLabels":23,"otherNames":18},"DRUG","ivermectin",[9],[25],{"name":26,"affiliation":27,"role":28},"sherief Abd-Elsalam, Ass. Prof.","Tanta University - Faculty of Medicine","PRINCIPAL_INVESTIGATOR",[30],{"name":31,"role":32,"phone":33,"phoneExt":18,"email":34},"Sherief Abd-Elsalam, ass. prof.","CONTACT","00201147773440","sheriefabdelsalam@yahoo.com",[36],{"facility":5,"status":37,"city":38,"state":18,"zip":39,"country":40,"countryCode":41,"cosmosGeoPoint":42,"geoPoint":47,"contacts":48},"RECRUITING","Tanta","35111","Egypt","EG",{"type":43,"coordinates":44},"Point",[45,46],31.00192,30.78847,{"lat":46,"lon":45},[49],{"name":50,"role":32,"phone":18,"phoneExt":18,"email":18},"Sherief Abd-Elsalam",{"type":28,"investigatorFullName":50,"investigatorTitle":52,"investigatorAffiliation":5,"oldNameTitle":18,"oldOrganization":18},"Ass. Prof. Tropical Medicine","100389474",false,"NCT04351347","The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment","Clinical Study Evaluating the Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment","Inclusion Criteria:\n\n* Patients with covid 19\n\nExclusion Criteria:\n\n* Allergy or side effects to treatment","ALL",{"count":61,"type":62},300,"ESTIMATED","INTERVENTIONAL",[65,66],"PHASE2","PHASE3","Efficacy of Ivermectin in larger doses in COVID-19 treatment",[69],"COVID","2021-03-08",{"date":72,"type":73},"2021-03-10","ACTUAL",{"date":75,"type":73},"2020-06-16",{"date":77,"type":62},"2030-12-01",{"name":5,"class":6},1]